RTOG 0625: A RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB WITH EITHER IRINOTECAN (CPT) OR DOSE-DENSE TEMOZOLOMIDE (TMZ) IN RECURRENT GLIOBLASTOMA (GBM) Conference

cited authors

  • Gilbert, Mark R; Wang, Meihua; Aldape, Kern; Sorensen, A Gregory; Mikkelsen, Tom; Bokstein, Felix; Woo, Shaio Y; Chmura, Steven J; Choucair, Ali K; Mehta, Minesh

fiu authors

publication date

  • November 1, 2010

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Science & Technology

Location

  • Hollywood, FL

Conference

  • Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

start page

  • 39

end page

  • 39

volume

  • 12